Cohance Lifesciences Limited (BOM:543064)
India
· Delayed Price · Currency is INR 1,078.65
+19.15 (1.81%)
At close: May 9, 2025
Cohance Lifesciences Revenue
Cohance Lifesciences had revenue of 3.07B INR in the quarter ending December 31, 2024, with 39.73% growth. This brings the company's revenue in the last twelve months to 10.48B, down -10.21% year-over-year. In the fiscal year ending March 31, 2024, Cohance Lifesciences had annual revenue of 10.51B, down -21.56%.
Revenue (ttm)
10.48B
Revenue Growth
-10.21%
P/S Ratio
26.17
Revenue / Employee
8.79M
Employees
1,193
Market Cap
274.37B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,627.08B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Hindustan Unilever | 631.21B |